 |
YA Global Master SPV Ltd Invests up to US$10,000,000 in Lotus Pharmaceutical, Inc. through Equity Line Facility 2010/03/03 |
 |
Lotus Pharmaceuticals
Announces New Prescription Drugs 2010/03/02 |
 |
Lotus Pharmaceuticals to Commence Sarbanes-Oxley Compliance Project 2010/03/01 |
 |
Lotus Pharmaceuticals
Announces Key Changes 2010/01/15 |
 |
Lotus Pharmaceuticals, Inc.
Appoints OTC Division Head 2009/12/10 |
 |
Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores 2009/11/30 |
 |
Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd
PHARMCHINA
2009/11/24 |
 |
Lotus
Pharmaceuticals,Inc. Reports Third-Quarter 2009 Results
2009/11/16 |
 |
Lotus
Pharmaceuticals,Inc. Announces Certain Clarification 2009/11/05 |
 |
Lotus Pharmaceuticals, Inc. Announces 2010 Growth Strategy 2009/10/19
|
 |
Lotus Reports Second Quarter 2009 Financial Results 2009/08/14 |
 |
Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets 2009/07/30 |
 |
Lotus Pharmaceuticals, Inc. Again Awarded GSP Certification 2009/06/29
|
 |
Lotus Pharmaceuticals, Inc. Reports First Quarter 2009
Financial Results 2009/05/18 |
 |
Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 2009/04/22 |
 |
Lotus Pharmaceuticals, Inc. Purchases Intellectual Property
Rights to an Established Prescription Drug 2009/02/18 |
 |
Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to
Grow its Business and Reduce Costs 2009/02/05 |
 |
Lotus Pharmaceuticals Announces Third Quarter 2008 Results 2008/11/18 |
 |
Lotus Pharmaceuticals Announces Second Quarter 2008 Results 2008/08/18 |
 |
|
 |
Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in
Meeting its Make Good Target for Fiscal Year 2008 2008/05/30 |
 |
|
 |
Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg 2008/04/24
|
 |
Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and
Fiscal Year 2007 Results 2008/04/17 |
 |
Lotus Pharmaceuticals Raises $5 Million in Private Placement 2008/02/26 |
 |
Lotus Pharmaceuticals, Inc. Implements
Environmentally-friendly Cost Saving Strategies 2008/02/07 |
 |
Lotus Pharmaceuticals, Inc. Achieves Significant Milestones
in the Development of Isosorbide Mononitrate Sustained
Release Tablets 2008/02/26 |
| |
|